Ischemic Stroke: The First Pass Effect

article image
ARTICLE SUMMARY:

Now that mechanical thrombectomy for acute ischemic stroke has proven itself to be a lifesaving therapy for many patients the bar is getting higher. Today’s goal is to restore the best possible quality of life to even more patients under the best economic scenario. To achieve this end, device innovators are pursuing several strategies, chief among them helping operators to get clots out on the first pass, which is linked to better outcomes.

It’s been less than five years since, beginning with MR CLEAN, a series of landmark trials validated the role of clot-removing (thrombectomy) devices that can open up large vessel occlusions in the anterior circulation of patients experiencing acute ischemic stroke. But the field is moving fast.

×

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?


Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.

All-Access

Questions?

We're here to help! Please contact us at: